Literature DB >> 20550

Catecholamine-sensitive adenylate cyclase of human fat cell ghosts: a comparative study using different beta-adrenergic agents.

H Kather, B Simon.   

Abstract

Some of the effects of beta-adrenergic agonists and antagonists on the adenylate cyclase system of human fat cell ghosts were studied. Isoproterenol, by causing about a fourfold increase of enzyme activity, was more potent than epinephrine and norepinephrine (about 2.5--3.0-fold stimulation). The beta2-adrenergic agonists salbutamol, terbutalin, and fenoterol were considerably less effective than the naturally occurring catecholamines. The stimulatory actions of isoproterenol and beta2-adrenergic agonists were competitively inhibited by the beta-blocking agent propranolol. Isoproterenol stimulation was also inhibited by the selective beta1-adrenergic antagonist practolol. This compound, however, was less potent than propranolol. The results are suggestive for an adenylate cyclase system in human fat cell ghosts coupled to beta1-adrenergic receptor sites. These receptors differ from the cardiac beta receptors with respect to practolol affinity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20550     DOI: 10.1016/0026-0495(77)90109-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  alpha-adrenoceptor mediated inhibition of human fat cell adenylate cyclase.

Authors:  H Kather; J Pries; V Schrader; B Simon
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

2.  Receptor-linked adenylate cyclase in the membranes of cultured human epidermal keratinocytes.

Authors:  M T Cavey; D Cavey; B Shroot; U Reichert; J Gazith
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  A comparative study of metabolic and hormonal responses to somatostatin and propranolol in man.

Authors:  D Giugliano; R Torella; S Sgambato
Journal:  Acta Diabetol Lat       Date:  1979 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.